Bloomberg News
@Bloomberg-News·2.8M subscribers·40.1K videos
Early Omicron Breakthroughs Show MRNA Vaccines’ Weakness
Posted
January 19, 2022
Views
793
Likes
16
Comments
11
Engagement
3.40%
January 19, 2022
793
16
11
3.40%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
0:59Now PlayingBooster shots with messenger RNA vaccines such as those made by Pfizer Inc. and BioNTech SE failed to block omicron in a study of some of the first documented breakthrough cases caused by the highly contagious variant.
Seven German visitors to Cape Town experienced symptomatic Covid-19 infections between late November and early December despite being boosted, the researchers, whose investigation was authorized by the University of Cape Town and Stellenbosch University, said in findings published Tuesday in The Lancet. All the cases were mild or moderate, providing support for the extra shots’ ability to fend off severe disease, death and hospitalizations.
Subscribe to our YouTube channel
Subscribe to our newest channel Quicktake Explained
Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
To watch complete coverage on Bloomberg Quicktake 24/7, visit or watch on Apple TV, Roku, Samsung Smart TV, Fire TV and Android TV on the Bloomberg app.
Have a story to tell? Fill out this survey for a chance to have it featured on Bloomberg Quicktake
Connect with us on…
Breaking News on YouTube
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
